Advancing the Future of Diagnostics & Regulatory Innovations
Event Navigation
Tuesday, February 4, 2025
10AM – 2PM ET
The Ritz Carlton
1150 22nd St NW, Washington, DC 20037
Conference will also be streamed virtually
Friends of Cancer Research (Friends) is hosting a meeting focused on driving innovation in diagnostics and regulatory policy. Key discussions will highlight evidence generation for novel technologies for diagnostic testing, including digital pathology and artificial intelligence (AI), along with strategies for developing diagnostic tests for rare biomarkers and addressing future regulatory considerations for cutting-edge tools. New data will be released from the ongoing Digital PATH Project, which leveraged a common dataset to evaluate variability across digital pathology platforms. This meeting brings together key thought leaders to explore how these innovations can accelerate progress in precision medicine and improve patient outcomes.
10:00AM: Welcoming Remarks
10:05AM: Morning Keynote
- Michelle Tarver, Director, CDRH, U.S. FDA
10:30AM: Panel 1 Discussion: Evaluating Digital Pathology and AI in Diagnostics
11:30AM: Break
11:45AM: Panel 2 Discussion: Validating Diagnostic Tests for Rare Biomarkers
12:45PM: Lunch
1:15PM: Panel 3 Discussion: Advancing Regulatory Frameworks and Policies for AI in Healthcare
1:55PM: Closing Remarks
2:00PM: Meeting Adjourned
Draft agenda is subject to change.
APAPP sponsor Biodesix is a contributing author to a publication that will be released during this event.
